Key Drivers
- Strong cash flow
- High leverage
- Intangible concentration
AIAI Summary
AdaptHealth is now a capital-allocation-and-execution wager rather than a pure growth story—its strong FCF and insider buying create real upside only if management demonstrates timely capitated contract revenue/margin ramps, stabilizes adjusted EBITDA, drives net leverage toward <2.0x, and prevents receivables/working-capital stress or governance distractions, so investors should only accumulate on clear, measurable evidence of those outcomes.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong cash flow
- •High leverage
- •Intangible concentration
AHCO generates strong operating cash flow and trades below tangible book but carries high leverage, concentrated intangibles, and volatile/negative recent profitability that threaten short‑term liquidity.
Price Behavior
Key Price Behavior Insights:
- •Slight mean reversion
- •Lower highs sequence
- •Quick recovery from low
Price slightly above last month's 21-day mean near $9.79 but overall showed a mild downtrend from $10.34 to ~ $9.9 with support at $8.86 and $9.15–$9.40 and resistance around $10.30–$10.60, implying short-term stabilization but limited upside until that resistance is cleared.
Volatile spike to $10.47 on 2026-03-18 amid overall down-leg
Sentiment & News
Key News Insights:
- •Record patient metrics
- •Earnings-per-share miss
- •Probe vs insider buy
AdaptHealth shows operational momentum with record patient metrics but missed Q4 EPS and now faces a governance probe amid institutional selling and insider buying.
Mixed operational progress alongside governance and earnings concerns will likely keep AHCO shares volatile, with downside risk offset partially by insider buying
Similar Companies in Healthcare
Other companies in the same sector with AI ratings